NewGenIvf Group (NewGenIvf Group) Debt-to-Revenue : N/A (As of Jun. 2023)

View and export this data going back to 2024. Start your Free Trial

What is NewGenIvf Group Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

NewGenIvf Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.20 Mil. NewGenIvf Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2023 was $0.16 Mil. NewGenIvf Group's annualized Revenue for the quarter that ended in Jun. 2023 was $0.00 Mil.

NewGenIvf Group Debt-to-Revenue Historical Data

The historical data trend for NewGenIvf Group's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NewGenIvf Group Debt-to-Revenue Chart

NewGenIvf Group Annual Data

Trend

Dec21

Dec22

Debt-to-Revenue

0.23

0.08

NewGenIvf Group Quarterly Data
	Dec21	Jun22	Dec22	Jun23
Debt-to-Revenue	N/A	N/A	N/A	N/A

Competitive Comparison of NewGenIvf Group's Debt-to-Revenue

For the Medical Care Facilities subindustry, NewGenIvf Group's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NewGenIvf Group's Debt-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NewGenIvf Group's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where NewGenIvf Group's Debt-to-Revenue falls into.

NewGenIvf Group Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

NewGenIvf Group's Debt-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.203	+	0.249)	/	5.944
	=	0.08

NewGenIvf Group's annualized Debt-to-Revenue for the quarter that ended in Jun. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(0.196	+	0.157)	/	0
	=	N/A

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jun. 2023) Revenue data.

NewGenIvf Group Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of NewGenIvf Group's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

NewGenIvf Group (NewGenIvf Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NewGenIvf Group Ltd (NAS:NIVF) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sukhumvit 21 Road, Asoke, 36/39-36/40, 13th Floor, PS Tower, Khlong Toei Nuea Sub-district, Watthana District, Bangkok, THA, 10110

Website

https://www.newgenivf.com

NewGenIvf Group Ltd is a company engaged in providing assisted reproductive services in Asia Pacific with a focus on providing fertility treatments to fulfil the dreams of building families, NewGenIvf mainly offers two services, namely first which is a in-vitro fertilization (IVF) treatment service, comprising traditional IVF and egg donation; and surrogacy and ancillary caring services.

NewGenIvf Group (NewGenIvf Group) Headlines

From GuruFocus

NewGenIvf Signs Non-Binding Term Sheet for Potential Reverse Merger with European Wellness Investment Holdings

By Marketwired • 04-22-2024